6 research outputs found
Neoadjuvant biomarker research study of palbociclib combined with endocrine therapy in estrogen receptor positive/HER2 negative breast cancer: The phase II NeoRHEA trial.
info:eu-repo/semantics/publishe
Plasma circulating tumor DNA as an alternative to metastatic biopsies for mutational analysis in breast cancer.
Molecular screening programs use next-generation sequencing (NGS) of cancer gene panels to analyze metastatic biopsies. We interrogated whether plasma could be used as an alternative to metastatic biopsies.SCOPUS: ar.jinfo:eu-repo/semantics/publishe